Sign in
4

Changes in Ownership

BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001181431-06-053723

Options or other derivatives

  • Director acquired 100,000 shares (grant or award)
  • Director returned 100,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

ARBEL IRIT · Director

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2006-09-17 Returned to the company : show line 1 in the form Stock Option (right to buy) −100,000 $0.75 2015-05-27 100,000 0 D
2006-09-17 Grant or award : show line 2 in the form Stock Option (right to buy) +100,000 $0.15 2015-05-27 100,000 100,000 D
Loading xslF345X02/rrd130719.xml…